MXPA03000500A - Use of il-8 receptor antagonists in the treatment of virus infections. - Google Patents

Use of il-8 receptor antagonists in the treatment of virus infections.

Info

Publication number
MXPA03000500A
MXPA03000500A MXPA03000500A MXPA03000500A MXPA03000500A MX PA03000500 A MXPA03000500 A MX PA03000500A MX PA03000500 A MXPA03000500 A MX PA03000500A MX PA03000500 A MXPA03000500 A MX PA03000500A MX PA03000500 A MXPA03000500 A MX PA03000500A
Authority
MX
Mexico
Prior art keywords
treatment
receptor antagonists
virus infections
infections
virus
Prior art date
Application number
MXPA03000500A
Other languages
Spanish (es)
Inventor
Susan B Dillon
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MXPA03000500A publication Critical patent/MXPA03000500A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
MXPA03000500A 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections. MXPA03000500A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21905300P 2000-07-18 2000-07-18
PCT/US2001/022328 WO2002005814A1 (en) 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections

Publications (1)

Publication Number Publication Date
MXPA03000500A true MXPA03000500A (en) 2003-06-24

Family

ID=22817645

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000500A MXPA03000500A (en) 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections.

Country Status (17)

Country Link
EP (1) EP1307190A4 (en)
JP (1) JP2004509852A (en)
KR (1) KR20030019587A (en)
CN (1) CN1449285A (en)
AR (1) AR033830A1 (en)
AU (1) AU2001273497A1 (en)
BR (1) BR0112603A (en)
CA (1) CA2418162A1 (en)
CZ (1) CZ2003132A3 (en)
HU (1) HUP0300754A3 (en)
IL (1) IL153921A0 (en)
MX (1) MXPA03000500A (en)
NO (1) NO20030201L (en)
NZ (1) NZ523659A (en)
PL (1) PL365886A1 (en)
WO (1) WO2002005814A1 (en)
ZA (1) ZA200300474B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509143A (en) * 2004-08-04 2008-03-27 シェーリング コーポレイション Pharmaceutical formulations containing pleconaril for the treatment of airway diseases
CN107072976A (en) * 2014-05-12 2017-08-18 葛兰素史克知识产权第二有限公司 The pharmaceutical composition for including Danirixin for treating communicable disease
EP4125848A1 (en) * 2020-03-26 2023-02-08 Dompe' Farmaceutici SpA Cxcl8 inhibitors for use in the treatment of covid-19
EP3884932A1 (en) * 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) * 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
AU3539795A (en) * 1994-08-25 1996-03-14 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp Il-8 receptor antagonists
SE9802729D0 (en) * 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
SE9802937D0 (en) * 1998-09-01 1998-09-01 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
NO20030201D0 (en) 2003-01-15
AR033830A1 (en) 2004-01-07
HUP0300754A2 (en) 2003-08-28
CA2418162A1 (en) 2002-01-24
NO20030201L (en) 2003-03-17
WO2002005814A1 (en) 2002-01-24
JP2004509852A (en) 2004-04-02
CZ2003132A3 (en) 2003-09-17
EP1307190A4 (en) 2007-08-22
BR0112603A (en) 2004-08-24
ZA200300474B (en) 2004-08-17
HUP0300754A3 (en) 2009-03-02
EP1307190A1 (en) 2003-05-07
NZ523659A (en) 2006-01-27
IL153921A0 (en) 2003-07-31
CN1449285A (en) 2003-10-15
PL365886A1 (en) 2005-01-10
KR20030019587A (en) 2003-03-06
AU2001273497A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
EE05507B1 (en) Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia
MXPA03004915A (en) Mch antagonists and their use in the treatment of obesity.
HK1056877A1 (en) Mch antagonists and their use in the treatment of obesity.
DE60143422D1 (en) INTERCONNECTS
EE200300544A (en) 4-Anilinoquinoline-3-carboxamides, their use and preparation
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
HK1053118A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof.
BR0105640B1 (en) disposable dressing article.
HK1046845B (en) Vibrator for lower limbs, and chair type vibrator using the vibrator
BR0209135B1 (en) disposable dressing article.
BR0113116B1 (en) bathtub.
MXPA03004932A (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors.
AR027945A1 (en) USE OF PRAMIPEXOL IN THE TREATMENT OF ADDICTION DISORDERS
HUP0300599A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
DE60119875D1 (en) Interconnects
DE60106146D1 (en) Interconnects
DE60109670D1 (en) Interconnects
DE60112673D1 (en) Interconnects
DE60107134D1 (en) Interconnects
MXPA03000500A (en) Use of il-8 receptor antagonists in the treatment of virus infections.
HUP0300470A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
EP1322319A4 (en) Use of il-8 protein modulators in the treatment of viral infections
MXPA03008393A (en) Bicyclic guanidine derivatives and therapeutic uses thereof.
ZA200403530B (en) Chemokine receptor antagonists and methods of use thereof.